Back to Trades
Other4
HALOZYME THERAPEUTICS, INC.
HALO
Total Value
$0
Company Information
- Company Name
- HALOZYME THERAPEUTICS, INC.
- Ticker Symbol
- HALO
- CIK
- 0001159036
Insider Information
- Name
- Torley Helen
- Role
- PRESIDENT AND CEO, Director
- Location
- SAN DIEGO, CA
DirectorOfficer
Filing Details
- Filing Date
- Dec 11, 2025
- Transaction Date
- Dec 9, 2025
- Accession Number
- 0001159036-25-000073
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Dec 9, 2025 | Derivative | 165,522 | — | Grant/Award | — |
Footnotes
- (F1)Represents the grant of performance-based vesting Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of HALO common stock. The target number of Restricted Stock Units subject to the award is indicated. Up to two hundred percent (200%) of the target Restricted Stock Units could vest if the average closing price of HALO common stock over a period of 20 consecutive trading days during a four-year performance period following the grant of the award equals or exceeds certain price levels specified in the award (with 50% of target number of units vesting at $115 and an additional 50% of the target number of units vesting at each of $130, $145 and $170) and, in each case, only if the Reporting Person remains employed with the Registrant through the end of the performance period (subject to certain exceptions provided in the applicable award agreement).